Russia to develop new vaccine against Omicron variant
Gamaleya said that the center is studying whether its Sputnik V and Sputnik Light vaccines can neutralize the Omicron variant as it believes
Published:
30 Nov 2021 10:00pm IST
30 Nov 2021 10:00pm IST
Russia's Gamaleya National Research Center of Epidemiology and Microbiology has said it has begun developing a new version of Sputnik vaccine adapted to target the Omicron variant of Covid-19.
Gamaleya in a statement on Monday added that the center is studying whether its Sputnik V and Sputnik Light vaccines can neutralize the Omicron variant as it believes, Xinhua news agency reported.
The heavily mutated Omicron coronavirus variant is likely to spread internationally and poses a very high risk of infection surges that could have "severe consequences" in some places.If modification is needed, the new Sputnik Omicron version can be ready for mass production in 45 days, the center said, hoping that a great amount of Sputnik Omicron booster shots can enter international markets in early 2022.
The heavily mutated Omicron coronavirus variant is likely to spread internationally and poses a very high risk of infection surges that could have "severe consequences" in some places, the World Health Organization (WHO) said on Monday.
No Omicron-linked deaths had yet been reported, though further research was needed to assess its potential to escape protection against immunity induced by vaccines and previous infections, it added.
Be the first to start a discussion here. Sign-in to write a comment now!
